Beta BionicsBBNX +1.71%10 Days Payable is 29.83 as of Mar. 2026, which is 7% below its 10-year median of 32.04. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Beta Bionics ranks worse than 86.92% on this metric.
The historical rank and industry rank for Beta Bionics's Days Payable or its related term are showing as below:
BBNX'
s Days Payable Range Over the Past 10 Years
Min: 25.08 Med: 32.04 Max: 51.22
Current: 28.83
During the past 4 years, Beta Bionics's highest Days Payable was 51.22. The lowest was 25.08. And the median was 32.04.
BBNX's Days Payable is ranked worse than 86.92% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs BBNX: 28.83
Beta Bionics's Days Payable
declined
from Mar. 2025 (33.19) to Mar. 2026 (29.83).
It may suggest that Beta Bionicsaccelerated paying its suppliers.
Beta Bionics Days Payable Related Terms
Beta Bionics Days Payable Historical Data
* Premium members only.
The historical data trend for Beta Bionics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Beta Bionics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beta Bionics Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beta Bionics's Days Payable distribution charts can be found below:
* The bar in red indicates where Beta Bionics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Beta Bionics's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beta Bionics (BBNX) has a Days Payable of 29.83 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beta Bionics and its competitors. This is near median its historical median of 32.04. Over the past decade, Beta Bionics' Days Payable has ranged from 25.08 to 51.22. According to the industry distribution chart, Beta Bionics ranks #691 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 86.9%.
Is Beta Bionics' Days Payable too high?
Beta Bionics' current Days Payable of 29.83 is near median its 10-year median of 32.04. Over the past 10 years, this metric has ranged from a low of 25.08 to a high of 51.22. The Medical Devices & Instruments industry median Days Payable is 68.07. Beta Bionics' value of 29.83 is 56.2% below this industry median. Based on the distribution chart, Beta Bionics ranks #691 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Days Payable compare to CBLL and SIBN?
According to the Medical Devices & Instruments industry distribution chart, Beta Bionics ranks #691 out of 795 companies for Days Payable. This places Beta Bionics in the lower half of its industry. The industry median Days Payable is 68.07. Beta Bionics' value of 29.83 is 56.2% below this benchmark. Historically, Beta Bionics' own Days Payable has ranged from 25.08 to 51.22 over the past decade. While the company's 10-year median is 32.04 vs. the industry median of 68.07, Beta Bionics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beta Bionics's current Days Payable of 29.83 is 56.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beta Bionics and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beta Bionics's current Days Payable is 29.83, which is near median its own 10-year median of 32.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Days Payable of 29.83. The current Days Payable is 29.83, which is near median its 10-year median of 32.04 and 56.2% below the Medical Devices & Instruments industry median of 68.07. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Days Payable is 29.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score
Get the complete analysis for BBNX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBNX has been successfully added to your 
